Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual agonist it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
One to two minutes at room temperature is sufficient
Future studies are needed to compare this treatment approach to other weight loss methods to further elucidate the role of GLP-1 agonists in weight loss
The process begins with a thorough consultation where we discuss your health history, current concerns, and what you hope to achieve
Fill out the form below, and we will be in touch shortly.
Protocol Compliance: Consistent daily dosing throughout the treatment period produces better results than sporadic use
US$ 22.06
US$ 25.81
US$ 23.50
US$ 24.75
US$ 22.02
US$ 29.66
